ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Eisai to supply generic drug makers with bulk ingredients

Eisai's Indian plant will be expanded to lift output of pharmaceutical ingredients.

TOKYO -- In an unprecedented step among leading Japanese pharmaceutical companies, Eisai has decided to sell active pharmaceutical ingredients to domestic generic drug makers.

     In preparation, Eisai will invest several billion yen (tens of millions of dollars) to double the production capacity of its manufacturing facility in southern India to 60 tons a year. The new lines are scheduled to become operational at the end of 2017. The additional annual output of 30 tons at the plant in Andhra Pradesh will account for more than 10% of Eisai's total capacity for active pharmaceutical ingredients.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more